Cannabis Extracts Show Potential in Improving Chronic Health Conditions

05/10/2023
cannabis products in front of a doctor

The Impact of Chronic Health Conditions

Living with one or more chronic health conditions can significantly diminish an individual's quality of life. While the health condition itself can be debilitating, the pharmaceutical medications prescribed to manage these conditions often come with their own set of challenges, further affecting the patient's well-being.

Medical Cannabis: A Viable Alternative?

Medical cannabis has emerged as a potential alternative to traditional pharmaceuticals. A recent study conducted in Australia reported improvements in quality of life among patients with various chronic conditions who were prescribed cannabis extracts, although its design cannot show that the extracts caused these changes.

Details of the Australian Study

The study, which was shared via a news release from NORML, was led by researchers at the University of Sydney and recruited patients through 120 clinicians in six Australian states. It was a prospective observational study without a control group that aimed to assess health-related quality of life, pain, fatigue, sleep, anxiety and depression in patients newly prescribed medicinal cannabis. The University of Sydney received funding for the study from Little Green Pharma, the maker of the cannabis oil products prescribed.

Of 2,762 patients who consented, 2,327 completed at least one follow-up questionnaire and were included in the analysis. They had been prescribed cannabis oil products with varying concentrations of THC and CBD and reported their outcomes over a three-month period.

Key Findings

The results of the study were promising. Patients reported statistically significant and clinically meaningful improvements in their health-related quality of life after starting cannabis extracts. The findings align with other large observational studies, such as a UK registry study, that have reported improvements after patients started cannabis-based treatment. Specifically, in the Australian study:

  • Overall health-related quality of life showed marked improvement over the three-month period.
  • Patients with chronic pain reported notable relief in their pain scores.
  • Those suffering from depression and anxiety also reported significant improvements in their respective scores.

Implications and Conclusions

The study's authors concluded that their findings suggest prescribing medical cannabis in clinical practice may alleviate symptoms of pain, fatigue, anxiety and depression in patients with chronic health conditions and improve their overall quality of life. They also found no change in sleep disturbance and noted that, because the study had no control group, some of the improvement may be due to placebo effects. The findings from this research contribute insights that can inform decision-making at both clinical and policy levels.

Medical Cannabis in Australia

In Australia, patients with chronic health conditions who have not responded to conventional treatment can be prescribed medicinal cannabis by clinicians with approval from the Therapeutic Goods Administration. The study's findings are consistent with potential benefits of such an approach, but because it did not compare cannabis extracts with other treatments, it cannot show that they are a more effective option for patients with chronic conditions.

Final Thoughts

The growing body of research into the potential benefits of medical cannabis for chronic health conditions underscores the need for further research, including controlled trials, and policy reforms. As more countries and regions explore the potential of cannabis as a therapeutic agent, it's crucial to base decisions on scientific evidence and patient experiences. The Australian study adds real-world data on the potential of cannabis extracts to improve the lives of those living with chronic health conditions.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.

Robin Roy Krigslund-Hansen

Robin Roy Krigslund-Hansen

About the author

Robin Roy Krigslund-Hansen is the founder and CEO of Formula Swiss and is responsible for formulation. Since founding the company in 2013, he has written about hemp, CBD, and the cannabis industry. His perspective draws on building Formula Swiss, conversations with researchers, and supporting CBD research.

More about Robin Roy Krigslund-Hansen

Related products